Related Experiment Video
Updated: Jun 16, 2026

07:40
Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
17.2K
The Design of Large-Scale Plasma Donation Trials.
Kecheng Li1, Richard J Cook1,2
1Department of Statistics and Actuarial Science, University of Waterloo, Ontario, Canada.
Statistics in Medicine
|July 15, 2025
Summary
This study presents a statistical framework to evaluate blood donation device safety, accounting for donor variability and rare adverse events. The developed methods ensure accurate trial design for comparing new devices against standard ones.
Area of Science:
- Biostatistics
- Clinical Trial Design
- Blood Donation Safety
Background:
- Evaluating new blood donation devices requires robust statistical methods due to challenges like non-independent donations, rare adverse events, and donor heterogeneity.
- Existing methods may not adequately address the complexities of analyzing safety outcomes in repeated donation scenarios.
Purpose of the Study:
- To develop a statistical framework for designing superiority and non-inferiority trials to assess the safety of new blood donation devices.
- To provide a method for planning accrual and follow-up periods based on historical donation data.
Main Methods:
- A statistical framework using generalized estimating equations with a working independence assumption was developed.
- A Poisson approximation with a log link and identity variance function was used to model binary donation-specific outcomes.
- Historical data on donation intensity, heterogeneity, adverse event rates, and serial dependence informed the planning and variance estimation.
Main Results:
- The derived statistical formulae demonstrated good control of type I error rates and statistical power.
- The framework enables effective planning of clinical trials for blood donation devices.
- Application to a plasma donation trial showed the utility for investigating serious hypotensive adverse events.
Conclusions:
- The developed statistical framework provides a reliable approach for designing and analyzing clinical trials comparing blood donation devices.
- This methodology addresses key challenges in donation safety research, including rare events and donor-specific factors.
- The study offers a practical tool for ensuring donor safety in the development of new blood collection technologies.

